Charles River Laboratories | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Agilent USD 6.14B 109M 2025-04
Align Technology USD 3.79B 57.74M 2025-03
Bio-Rad Laboratories USD 7.13B 449.3M 2025-06
Bruker USD 1.83B 35.8M 2025-03
Cardinal Health USD -2948000000 43M 2025-03
Charles River Laboratories USD 3.31B 119.03M 2025-06
Cigna USD 40.43B 204M 2025-06
CVS Health USD 77.55B 622M 2025-06
Danaher USD 52.33B 1.48B 2025-06
Dentsply International USD 2.01B 68M 2025-03
Elevance Health USD 43.85B 1.35B 2025-06
Galapagos EUR 2.64B 104.07M 2025-06
Hologic USD 4.84B 223.8M 2025-06
Humana USD 18.3B 544M 2025-06
Illumina USD 2.26B 110M 2025-06
Incyte USD 4.17B 503.34M 2025-06
IQVIA Holdings USD 5.78B 199M 2025-06
Laboratory Of America USD 8.47B 151M 2025-06
Lonza CHF 9.33B 23M 2024-12
McKesson USD -1967000000 107M 2025-06
Merck EUR 29.9B 89M 2025-03
Mettler Toledo International USD -258793000 76.81M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Quest Diagnostics USD 7.23B 299M 2025-06
Revvity USD 7.64B 29.74M 2025-03
Thermo Fisher Scientific USD 49.36B 227M 2025-03
United Therapeutics USD 7.17B 366.4M 2025-06
UnitedHealth USD 100.81B 8.15B 2025-03
Walgreens Boots Alliance USD 7.32B 209M 2025-05
Waters USD 2.16B 197.42M 2025-06
West Pharmaceutical Services USD 2.93B 246M 2025-06


Charles River Laboratories Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.